Alpha Teknova (TKNO) Competitors

Amphastar Pharmaceuticals (NASDAQ:AMPH) and Alpha Teknova (NASDAQ:TKNO) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, institutional ownership, risk, community ranking, valuation, media sentiment, analyst recommendations, dividends and earnings.

Does the media refer more to AMPH or TKNO?

In the previous week, Amphastar Pharmaceuticals had 7 more articles in the media than Alpha Teknova. MarketBeat recorded 8 mentions for Amphastar Pharmaceuticals and 1 mentions for Alpha Teknova. Alpha Teknova's average media sentiment score of 1.87 beat Amphastar Pharmaceuticals' score of 0.93 indicating that Alpha Teknova is being referred to more favorably in the news media.

Company	Overall Sentiment
Amphastar Pharmaceuticals	Positive
Alpha Teknova	Very Positive

Is AMPH or TKNO more profitable?

Amphastar Pharmaceuticals has a net margin of 21.80% compared to Alpha Teknova's net margin of -87.17%. Amphastar Pharmaceuticals' return on equity of 26.44% beat Alpha Teknova's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Amphastar Pharmaceuticals	21.80%	26.44%	11.89%
Alpha Teknova	-87.17%	-35.30%	-24.52%

Do analysts recommend AMPH or TKNO?

Amphastar Pharmaceuticals presently has a consensus price target of $32.33, indicating a potential upside of 22.34%. Alpha Teknova has a consensus price target of $8.50, indicating a potential upside of 44.56%. Given Alpha Teknova's stronger consensus rating and higher probable upside, analysts plainly believe Alpha Teknova is more favorable than Amphastar Pharmaceuticals.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Amphastar Pharmaceuticals	0 Sell rating(s)	3 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.25
Alpha Teknova	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00

Do insiders and institutionals hold more shares of AMPH or TKNO?

65.1% of Amphastar Pharmaceuticals shares are owned by institutional investors. Comparatively, 13.8% of Alpha Teknova shares are owned by institutional investors. 27.5% of Amphastar Pharmaceuticals shares are owned by insiders. Comparatively, 12.5% of Alpha Teknova shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Which has stronger earnings & valuation, AMPH or TKNO?

Amphastar Pharmaceuticals has higher revenue and earnings than Alpha Teknova. Alpha Teknova is trading at a lower price-to-earnings ratio than Amphastar Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Amphastar Pharmaceuticals	$730.66M	1.71	$137.54M	$2.76	9.58
Alpha Teknova	$38.25M	8.22	-$36.78M	-$0.48	-12.25

Which has more volatility and risk, AMPH or TKNO?

Amphastar Pharmaceuticals has a beta of 0.77, meaning that its stock price is 23% less volatile than the S&P 500. Comparatively, Alpha Teknova has a beta of 0.4, meaning that its stock price is 60% less volatile than the S&P 500.

Does the MarketBeat Community believe in AMPH or TKNO?

Amphastar Pharmaceuticals received 384 more outperform votes than Alpha Teknova when rated by MarketBeat users. Likewise, 65.83% of users gave Amphastar Pharmaceuticals an outperform vote while only 39.13% of users gave Alpha Teknova an outperform vote.

Company	Underperform	Outperform
Amphastar Pharmaceuticals	Outperform Votes 393 65.83%	Underperform Votes 204 34.17%
Alpha Teknova	Outperform Votes 9 39.13%	Underperform Votes 14 60.87%

Summary

Amphastar Pharmaceuticals beats Alpha Teknova on 13 of the 18 factors compared between the two stocks.